CARE Canadian ALS Riluzole Evaluation

Summary

Evaluate the efficacy of riluzole 50-mg bid defined by comparing the percentage of riluzole-treated subjects who experienced death, permanently assisted ventilation (PAV) or tracheostomy, to a group of recent historical controls for the treatment of amyotrophic lateral sclerosis (ALS).

Timeline

Start

2001-01

Primary completion

—

Completion

2004-12

Drugs

Indications